These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 18068527
1. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM. Cancer Genet Cytogenet; 2008 Jan 01; 180(1):14-9. PubMed ID: 18068527 [Abstract] [Full Text] [Related]
2. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Sreeja L, Syamala V, Raveendran PB, Santhi S, Madhavan J, Ankathil R. Cancer Invest; 2008 Feb 01; 26(1):41-6. PubMed ID: 18181044 [Abstract] [Full Text] [Related]
3. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M. Cancer Genet Cytogenet; 2010 Dec 01; 203(2):263-8. PubMed ID: 21156242 [Abstract] [Full Text] [Related]
5. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J. Lung Cancer; 2006 Apr 01; 52(1):9-14. PubMed ID: 16499995 [Abstract] [Full Text] [Related]
7. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW. Brain Res Mol Brain Res; 2005 Jun 13; 137(1-2):98-103. PubMed ID: 15950766 [Abstract] [Full Text] [Related]
11. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Santos AM, Sousa H, Catarino R, Pinto D, Pereira D, Vasconcelos A, Matos A, Lopes C, Medeiros R. Cancer Genet Cytogenet; 2005 Jun 13; 159(2):143-7. PubMed ID: 15899386 [Abstract] [Full Text] [Related]
12. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P. Lung Cancer; 2007 Jan 13; 55(1):25-34. PubMed ID: 17059853 [Abstract] [Full Text] [Related]
14. Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis. Lattuada D, Viganò P, Somigliana E, Abbiati A, Candiani M, Di Blasio AM. Mol Hum Reprod; 2004 Sep 13; 10(9):651-4. PubMed ID: 15273281 [Abstract] [Full Text] [Related]
15. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. Int J Immunogenet; 2007 Jun 13; 34(3):213-7. PubMed ID: 17504512 [Abstract] [Full Text] [Related]
17. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R. Oncol Rep; 2006 Jul 13; 16(1):65-71. PubMed ID: 16786124 [Abstract] [Full Text] [Related]
18. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO. Cancer Detect Prev; 2006 Jul 13; 30(6):523-9. PubMed ID: 17113725 [Abstract] [Full Text] [Related]